Wegman Mark N 4/A
4/A · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jul 10, 2019
Insider Transaction Report
Form 4/AAmended
Wegman Mark N
Director
Transactions
- Award
Common Stock, $0.001 par value
2019-07-01+1,890→ 67,162 total
Footnotes (2)
- [F1]Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
- [F2]The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person due to a prior administrative error and does not represent any acquisition or disposition of shares by the reporting person.